Brain metastases confer a worse prognosis to breast cancer because they determine a severe increase in mortality. The aim of this study was to identify the early symptoms in patients with brain metastases after breast cancer treatment and to evaluate the median survival rate in women with single and operable brain lesions.
Patients and Methods
We examined 43 patients with brain metastases secondary to breast cancer treated in the Oncological Institute Prof I Chiricuţă, Cluj-Napoca, during the period 2000-2006.
Results
The median interval between the breast cancer diagnosis and detection of central nervous metastases was 21 months. The most frequent symptoms were headache, gait disturbance, nausea and vomiting. Patients with a single brain lesion had a median survival of 23 months compared to only 7 months in case of patients with multiple brain metastases.
Conclusions
The prognosis is worse in patients with solitary brain metastases secondary to breast cancer than in patients who present extracranial metastases. Among factors considered favorable in these patients are a single brain lesion, accessibility to surgery, and the absence of associated extracranial metastases.
KiricutaI.C., KiilblO., WillnerJ.: Central nervous system metastases in breast cancer.J Cancer Res Clin Oncol, 118: 542–546, 1992.
4.
Mu-TaiL., HsiehC., WangA., Tung-HaoC., Chu-PinP., Chia-ChunH., Chao-YuanH., Cheng-HongL.: Prognostic factors affecting the outcome of brain metastases from breast cancer.Support Care Cancer, 14: 936–942, 2006.
5.
RosnerD., FlowersA.: Management of brain metastases from breast carcinoma with systemic chemotherapy: current status of therapy.Radiother Med Oncol, 3: 250–263, 2000.
6.
BoogerdW., HartA., TjahjaI.: Treatment and outcome of brain metastasis as first site of distant metastasis from breast cancer.J Neurooncol, 35: 161–167, 1997.
7.
FokstuenT., WilkingN., RutqvistL.E., WolkeJ., LiedbergA., SignomklaoT., FernbergJ-O: Radiation therapy in the management of brain metastases from breast cancer.Breast Cancer Res Treat, 62: 211–216, 2000.
8.
GreceaD., VitocC., TodorN.: Prognostic factors in brain metastases of breast carcinoma.Radiother Med Oncol, 4: 407–413, 2000.
9.
BoogerdW., VosV., HartA., BarisG.: Brain metastases in breast cancer: natural history, prognostic factors and outcome.J Neurooncol, 15: 165–174, 1993.
10.
GasparL., ScottC., RotmanM., AsbellS., PhillipsT., WassermanT., McKennaW.G., ByhardtR.: Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.Int J Radiation Oncol Biol Phys, 37: 745–751, 1997.
11.
CareyL., EwendM., MetzgerR., SawyerL., DeesE.C., SartorC.I., MooreD.T., GrahamM.L.: Central nervous system metastases in women after multimodality therapy for high risk breast cancer.Breast Cancer Res Treat, 88: 273–280, 2004.
12.
PetrovichZ., YuC., GiannottaS., O'DayS., ApuzzoM.L.: Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery.J Neurosurg, 97: 499–506, 2002.
13.
CombsS., Schulz-ErtnerD., ThilmannC., LutzE., JurgenD.: Treatment of cerebral metastases from breast cancer with stereotactic radiosurgery.Strahlenther Onkol, 80: 590–596, 2004.
14.
FirlikK., KondziolkaD., FlickingerJ., LunsfordD.: Stereotactic radiosurgery for brain metastases from breast cancer.Ann Surg Oncol, 5: 333–338, 2000.
15.
RosnerD., NemotoT., PickrenJ., LaneW.: Management of brain metastases from breast cancer by combination chemotherapy.J Neurooncol, 1: 131–137, 1983.
16.
WronskiM., ArbitE., McCormickB.: Surgical treatment of 70 patients with brain metastases from breast carcinoma.Cancer, 80: 1746–1754, 1997.
17.
FlowersA., LevinV.: Management of brain metastases from breast carcinoma.Oncology, 7: 21–26, 1993.
18.
NiederC., AndratschkeN., GrosuA., MollsM.: Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.Strahlenther Onkol, 179: 16–20, 2003.
19.
LedermanG., WronskiM., FineM.: Fractionated radiosurgery for brain metastases in 43 patients with breast carcinoma.Breast Cancer Res Treat, 65: 145–154, 2001.
20.
TsukadaY., FouadA., PickrenJ., WarrenL.: Central nervous system metastasis from breast carcinoma – autopsy study.Cancer, 52: 2349–2354, 1983.
21.
ViadanaE., CotterR., PickrenJ., BrossI.: An autopsy study of metastatic sites of breast cancer.Cancer Res, 33: 179–181, 1973.
22.
PieperD., HessK., SawayaR.: Role of surgery in the treatment of brain metastases in patients with breast cancer.Ann Surg Oncol, 4: 481–490, 1997.
23.
ZimmS., WamplerG., StableinD., HazraT., YoungH.F.: Intracerebral metastases in solid tumor patients. Natural history and results of treatment.Cancer, 48: 384–394, 1981.
24.
BoogerdW., DalesioO., BaisE., Van der SandeJ.J.: Response of brain metastases from breast cancer to systemic chemotherapy.Cancer, 69: 972–980, 1992.
25.
AndreF., SlimaneK., BachelotT., DunantA., NamerM., BarrelierA., KabbajO., SpanoJ., MarsigliaH., RouzierR., DelalogeS., SpielmannM.: Breast cancer with synchronous metastases: trends in survival during a 14-year period.J Clin Oncol, 22: 3302–3308, 2004.
26.
WeilR., PalmieriD., BronderJ., StarkA.M., SteegP.S.: Breast cancer metastasis to the central nervous system.Am J Pathol, 167: 913–920, 2005.
27.
SperdutoP.: A review of stereotactic radiosurgery in the management of brain metastases.Technol Cancer Res Treat, 92: 105–110, 2003.
28.
DiStefanoA.Yap H, Hortobagyi G: The natural history of breast cancer patients with brain metastases.Cancer, 44: 1913–1918, 1976.
29.
NiederC., WalterK., NestleU., SchnabelK.: Ten years disease-free survival after solitary brain metastasis from breast cancer.J Cancer Res Clin Oncol, 122: 570–572, 1996.
30.
OrderS., HellmanS., Von EssenC., KligermanM.M.: Improvement in quality of survival following whole-brain irradiation for brain metastases.Radiology, 91: 149–151, 1968.
31.
NisceL., HilarisS., ChuF.: A review of experience with irradiation of brain metastases.Am J Roentgenol, 3: 329–333, 1971.
32.
PosnerJ., ShapiroW.: Brain tumor. Current status of treatment and its complications.Arch Neurol, 32: 781–784, 1975.
HoskinP., CrowJ., FordH.: The influence of extent and local management on the outcome of radiotherapy for brain metastases.Int J Radiation Oncology Biol Phys, 19: 111–115, 1990.
35.
RosnerD., NemotoT., LaneW.: Chemotherapy induces regression of brain metastases in breast carcinoma.Cancer, 58: 832–839, 1986.
36.
HendersonI., GarberJ., BrettmeyerJ., HayesD.F., HarrisJ.R.: Comprehensive management of disseminated breast cancer.Cancer, 66: 1439–1448, 1990.
37.
PiccirilliM., Enny SassunT., BrognaC., GiangasperoF., SalvatiM.: Late brain metastases from breast cancer: clinical remarkson 11 patients and review of the literature.Tumori, 93: 150–154, 2007.
